Maladies rénales fréquentes et rares

• Article dans une revue

Biomarkers in acute kidney injury settings to predict interventions and outcomes: the MARKISIO study

Khalil Chaïbi, Adrien Picod, Marouane Boubaya, Sarah Tubiana, Vincent Jullien, Sophie Magreault, Sandrine Placier, Jérémie Mallet, Guillaume Louis, Laurent Martin-Lefevre, Dimitri Titeca-Beauport, Béatrice La Combe, Sébastien Besset, Julio Badie, Guillaume Chevrel, Nicolas Chudeau, Saber Barbar, Christophe Vinsonneau, Jean-Marie Forel, Didier Thevenin, Guillaume Lacave, Saad Nseir, Johanna Oziel, Julien Mayaux, Kada Klouche, Jean Reignier, Jean-Damien Ricard, Jean-Pierre Quenot, Alexandre Mebazaa, Feriel Azibani, Didier Dreyfuss, Stéphane Gaudry

Introduction: Predicting the need for renal replacement therapy (RRT) in acute kidney injury (AKI) remains challenging. The utility of biomarkers was explored during previous studies which were biased as RRT indications relied on clinician opinion rather than evidence. Those studies preceded trials…

Critical Care, 2025, 29 (1), pp.204. ⟨10.1186/s13054-025-05439-y⟩. ⟨hal-05081203⟩

• Article dans une revue

Synthetic Peptide Antibodies via a Rational Approach Based on Disulfide‐Stabilized α‐Helical Peptides, for the Recognition of the Intrinsically Disordered Protein NUPR1

Noel Angelo Kalacas, Bernadette Tse Sum Bui, Rodrigue Marquant, Franck Merlier, Irene Maffucci, Juliette Hadchouel, Pierre Galichon, Karsten Haupt

Abstract Nuclear Protein 1 (NUPR1) is a ubiquitous protein playing an important role in cancer and acute kidney injury. Its specific targeting by natural or synthetic antibodies like molecularly imprinted polymers (MIPs), is therefore of interest. NUPR1 is an intrinsically disordered protein (IDP…

Macromolecular Bioscience, 2025, pp.e70002. ⟨10.1002/mabi.202400605⟩. ⟨hal-05072934⟩

• Article dans une revue

Progressive Multifocal Leukoencephalopathy in Kidney Transplant Recipients: A Retrospective Multicenter Nationwide Case Series

Adélaïde Sanson, Yannis Lombardi, Rebecca Sberro-Soussan, François Provôt, Léonard Golbin, Samir Boudjeltia, Romain Pszczolinski, Christophe Masset, Anne-Sophie Vasseur, Jean-François Augusto, Hannah Kaminski, Eric Daugas, Sophie Caillard, Jean-Michel Rebibou, Valérie Moal, Moglie Le Quintrec, Renaud Snanoudj, Marie Matignon, Giovanna Melica, Julien Zuber, Laurent Mesnard, Nacera Ouali, Yosu Luque, Camille Petit-Hoang, Arnaud del Bello, Nassim Kamar, Hélène François

American Journal of Kidney Diseases, 2025, S0272-6386 (25), pp.00821-2. ⟨10.1053/j.ajkd.2025.02.606⟩. ⟨hal-05048336⟩

• Article dans une revue

Safety and Efficacy of Oral Direct Factor Xa Inhibitors in Patients With Nephrotic Syndrome: Results From a National Retrospective Study

Caroline Arches, Arwa Jalal-Eddine, Dimitri Titeca-Beauport, Myriam Dao, Thierry Lobbedez, Philippe Zaoui, Christophe Masset, Dominique Bertrand, Khalil El Karoui, Henri Brenier, Hamza Sakhi, Bastien Peiffer, Vincent Audard, Nizar Joher

Introduction: The optimal management of thromboembolism (TE) in patients with nephrotic syndrome (NS) remains challenging. Until now, anticoagulation therapy for NS consisted of vitamin K antagonists (VKAs) or heparin. Data on direct oral anticoagulant (DOAC) use in NS are limited, and their safety…

Kidney International Reports, 2025, 10 (4), pp.1188-1195. ⟨10.1016/j.ekir.2025.01.042⟩. ⟨hal-05054457⟩